A.R.T. Advisors’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
AA
A.R.T. Advisors's CDLX Position: Q1 2020 in Review
A.R.T. Advisors sold out of Cardlytics (CDLX) in Q1 2020, closing a stake of 321 shares — an estimated $201K sold.
A.R.T. Advisors first reported a position in CDLX in Q4 2018 and held it in 4 quarters. The position peaked at $1.4M in Q3 2019. 142 funds tracked by Wall St. Rank hold CDLX as of Q1 2020.
- A.R.T. Advisors reported no remaining Cardlytics position as of Q1 2020 after selling out during the quarter.
- A.R.T. Advisors sold 321 Cardlytics shares in Q1 2020, an estimated $201K.
- A.R.T. Advisors first reported a position in Cardlytics in Q4 2018 and held it in 4 quarters.
- A.R.T. Advisors's Cardlytics position peaked at $1.4M in Q3 2019.
- 142 funds tracked by Wall St. Rank held Cardlytics as of Q1 2020.
Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.